Drug-free, on-the-go therapy for improved breathing and pain relief
Chronic nasal congestion, a symptom of chronic rhinosinusitis and rhinitis, affects 1 in every 5 people, causing them to experience constant discomfort, pain and fatigue. Current treatments are associated with limited efficacy and safety concerns.
The globally patented* and design-protected BES-1001 device is the first drug-free, non-invasive and connected treatment that provides targeted, rapid relief from nasal congestion and related pain.
Currently in clinical development, BES-1001 is expected to be registered by early 2024.
*Patents: WO2020/245467 and WO2020/245466
How it works
BES-1001 delivers precisely-modulated acoustic energy (PMAE) that gently travels through the tissue to relieve sinus and nasal congestion, pressure and pain.
Clinical validation of mechanism of action
What users are saying about BES-1001
“I have been sleeping for the last 20 years with a CPAP machine, and in case of a cold or infection in my nose, I cannot use the CPAP. I have been using the BES-1001 consistently for 2 years, early in the morning and late at night and during these years I was not affected by any nose infections or cold so I was able to use the CPAP. Now, I always ensure that I carry the BES-1001 with me on all my travels, giving me the confidence and relief of breathing correctly.”
“When I have a cold, I manage to treat it successfully with the BES-1001. The BES-1001 has become a family device.”
“The device was very easy to use and comfortable during treatment. I felt immediately decongested and could breathe better!”
“I am happy to say that using the above device helped me to give up the cortisone nasal spray, and in a very short time”
“For me it is very important the device I feel really better!”
a game-changing medical device company
We are a Swiss medical device company that develops drug-free, non-invasive medical devices for the treatment of high-prevalence chronic nasal and pain conditions. Leveraging our network of international partners, we are committed to developing medical devices that harness the power of PMAE therapy and continue to research its applications in further indications.
We aim to reshape treatment paradigms with ground-breaking therapies that are effective, safe and that meaningfully address patient convenience.